Form 8-K - Current report:
SEC Accession No. 0001193125-21-091294
Filing Date
2021-03-23
Accepted
2021-03-23 16:57:02
Documents
13
Period of Report
2021-03-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d167902d8k.htm   iXBRL 8-K 24000
2 EX-99.1 d167902dex991.htm EX-99.1 55450
  Complete submission text file 0001193125-21-091294.txt   195366

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA neog-20210323.xsd EX-101.SCH 3064
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20210323_lab.xml EX-101.LAB 15319
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20210323_pre.xml EX-101.PRE 9662
6 EXTRACTED XBRL INSTANCE DOCUMENT d167902d8k_htm.xml XML 2920
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 21765433
SIC: 2835 In Vitro & In Vivo Diagnostic Substances